Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID STEROID: Hydrocortisone in COVID-19 and Severe Hypoxia
NCT04348305Phase 3Completed
- Sponsor
- Scandinavian Critical Care Trials Group
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in coronavirus disease 2019 (COVID-19), sponsored by Scandinavian Critical Care Trials Group. Started Apr 2020; status: completed.
02
Drugs
hydrocortisone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348305.